Rivista
/
Immunologia e infezioni
/
HLA-Ig Based Artificial Antigen Presenting Cells for Efficient ex vivo Expansion of Human CTL
JoVE Journal
Immunologia e infezioni
This content is Free Access.
JoVE Journal Immunologia e infezioni
HLA-Ig Based Artificial Antigen Presenting Cells for Efficient ex vivo Expansion of Human CTL

HLA-Ig Based Artificial Antigen Presenting Cells for Efficient ex vivo Expansion of Human CTL

15,103 Views

•

07:18 min

•

April 11, 2011

DOI:

10.3791/2801-v

DOI:
10.3791/2801-v

•

07:18 min
April 11, 2011

•

3 Views
, ,
1Immunology Graduate Program,Johns Hopkins University, 2Department of Internal Medicine,Far-Eastern Memorial Hospital, 3Department of Pathology,Johns Hopkins University, 4Institute of Cell Engineering,Johns Hopkins University

Summary

Automatically generated

A new DC independent method for induction and expansion of antigen-specific T cells is described. HLA A2-Ig based artificial Antigen Presenting Cells (aAPC) are loaded with HLA-A2 restricted peptides to efficiently expand CTL of diverse antigen specificity. This technology holds great potential for CTL-based adoptive immunotherapy.

Explore More Videos

HLA-IgArtificial Antigen Presenting CellsEx Vivo ExpansionHuman CTLEffector FunctionImmune MicroenvironmentAutologous Antigen Presenting CellsTolerizeAnergizeAdoptive ImmunotherapyCancerVirus InfectionsCMV-specific CTLImmunocompromised Allogeneic Bone Marrow Transplant PatientsAnti-CMV ImmunityMelanomaCost And Technical LimitationsAutologous DCLeukocytes

Read Article

Cite this Article

Chiu, Y., Schneck, J. P., Oelke, M. HLA-Ig Based Artificial Antigen Presenting Cells for Efficient ex vivo Expansion of Human CTL. J. Vis. Exp. (50), e2801, doi:10.3791/2801 (2011).

Download .ris file

Copy

Share Video

.

Copy